Hepatitis C can be treated and even cured. And treatment is important -- hepatitis C, caused by a virus, can permanently damage your liver if you don't take medicine for it.
Treatment for hepatitis C keeps changing quickly. The standard treatment was typically interferon along with other drugs -- usually ribavirin and either Victrelis (boceprevir) or Incivek (telaprevir). But newer drugs Olysio (simeprevir) and Solvadi (sofosbuvir) cure more people in less time with fewer side effects. Doctors...
In most cases, hepatitis B causes limited infection. Usually people manage to fight off the infection successfully within a few months, developing an immunity that lasts a lifetime (this means you won't get the infection again). Blood tests show evidence of this immunity, but no signs of active infection.
However, some people don't get rid of the infection. If you are infected with hepatitis B for more than six months, you are considered a carrier, even if you have no symptoms. This means that you can transmit the disease to others by having unprotected sex, exposing blood or open sores to another person, or sharing needles or syringes.
For unknown reasons, the infection eventually goes away in a small percentage of carriers. For others, the infection becomes chronic. Chronic hepatitis is an ongoing infection of the liver that can lead to cirrhosis and liver cancer. Cirrhosis, or hardening of the liver, causes liver tissue to scar and stop working.
If you are carrying the virus you should not donate blood, plasma, body organs, tissue, or sperm. Tell your doctor, dentist, and sex partner that you are a hepatitis B carrier.
How Common Is Hepatitis B?
According to the CDC, the number of people contracting hepatitis B has decreased from an average of 200,000 per year in the 1980s to 43,000 in 2007. The highest rate of infection occurs among those 20 to 49 years old.
Approximately 5% to 10% of adults and children older than age 5 with hepatitis B infection go on to develop chronic infection. These rates climb much higher for children younger than age 5 (25% to 50%) and even higher for infants infected at birth (90%).
Approximately 1.25 million people in the U.S. are carriers of the hepatitis B virus.